🇺🇸 FDA
Patent

US 6509334

Cyclocarbamate derivatives as progesterone receptor modulators

expired A61PA61P15/00A61P15/18

Quick answer

US patent 6509334 (Cyclocarbamate derivatives as progesterone receptor modulators) held by Ligand Pharmaceuticals Incorporated expires Mon Jan 16 2023 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
Ligand Pharmaceuticals Incorporated
Grant date
Tue Jan 21 2003 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 16 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
94
CPC classes
A61P, A61P15/00, A61P15/18, A61P35/00, A61P43/00